PWS
Peloton Wealth Strategists Portfolio holdings
AUM
$249M
This Quarter Return
-2.37%
1 Year Return
+10.61%
3 Year Return
+43.02%
5 Year Return
+84.84%
10 Year Return
–
AUM
$239M
AUM Growth
+$239M
(-3.5%)
Cap. Flow
-$36.6K
Cap. Flow
% of AUM
-0.02%
Top 10 Holdings %
Top 10 Hldgs %
31.71%
Holding
99
New
7
Increased
34
Reduced
39
Closed
7
Top Buys
| 1 |
Uber
UBER
|
$2.32M |
| 2 |
iShares MSCI EAFE Small-Cap ETF
SCZ
|
$1.78M |
| 3 |
Freeport-McMoran
FCX
|
$1.7M |
| 4 |
iShares Russell 2000 Value ETF
IWN
|
$1.58M |
| 5 |
Citigroup
C
|
$1.51M |
Top Sells
| 1 |
Garmin
GRMN
|
$2.37M |
| 2 |
JPMorgan Chase
JPM
|
$2.21M |
| 3 |
LyondellBasell Industries
LYB
|
$2.16M |
| 4 |
iShares Russell 1000 Value ETF
IWD
|
$1.73M |
| 5 |
Schwab US REIT ETF
SCHH
|
$1.67M |
Sector Composition
| 1 | Healthcare | 15.41% |
| 2 | Technology | 13.08% |
| 3 | Financials | 12.38% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Industrials | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Home Depot
HD
$405B
| $1.74M | 0.73% |
4,734
| – | – |
|
52
McDonald's
MCD
$224B
| $1.67M | 0.7% |
5,335
-75
| -1% | -$23.4K |
|
53
Neurocrine Biosciences
NBIX
$13.8B
| $1.66M | 0.69% |
14,990
+875
| +6% | +$96.8K |
|
|
54
iShares Russell 2000 Value ETF
IWN
$11.8B
| $1.58M | 0.66% |
+10,449
| New | +$1.58M |
|
|
55
Citigroup
C
$178B
| $1.51M | 0.63% |
+21,300
| New | +$1.51M |
|
56
Accenture
ACN
$162B
| $1.38M | 0.58% |
4,433
| – | – |
|
57
Synopsys
SNPS
$112B
| $1.35M | 0.57% |
3,153
+225
| +8% | +$96.5K |
|
58
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.25B
| $1.31M | 0.55% |
52,500
+7,500
| +17% | +$187K |
|
|
HPE.PRC
59
Hewlett Packard Enterprise Company 7.625% Series C Mandatory Convertible Preferred Stock
HPE.PRC
$1.89B
| $1.26M | 0.53% |
26,325
+13,775
| +110% | +$658K |
|
60
US Bancorp
USB
$76B
| $1.21M | 0.51% |
28,625
+400
| +1% | +$16.9K |
|
61
On Holding
ONON
$14.7B
| $1.18M | 0.49% |
26,810
-11,750
| -30% | -$516K |
|
62
Exelixis
EXEL
$10.1B
| $1.18M | 0.49% |
31,830
-13,000
| -29% | -$480K |
|
63
Danaher
DHR
$147B
| $1.14M | 0.48% |
5,581
-115
| -2% | -$23.6K |
|
64
Texas Pacific Land
TPL
$21.5B
| $1.14M | 0.48% |
863
-227
| -21% | -$301K |
|
65
Medtronic
MDT
$119B
| $1.14M | 0.47% |
12,630
+1,810
| +17% | +$163K |
|
66
Idexx Laboratories
IDXX
$51.8B
| $1.06M | 0.44% |
2,513
+1,953
| +349% | +$820K |
|
67
Eli Lilly
LLY
$657B
| $918K | 0.38% |
1,111
+44
| +4% | +$36.4K |
|
68
Novo Nordisk
NVO
$251B
| $880K | 0.37% |
+12,680
| New | +$880K |
|
69
Keysight
KEYS
$28.1B
| $771K | 0.32% |
5,145
-50
| -1% | -$7.49K |
|
70
Devon Energy
DVN
$22.9B
| $765K | 0.32% |
20,450
-1,500
| -7% | -$56.1K |
|
71
Diamondback Energy
FANG
$43.1B
| $707K | 0.3% |
4,420
-125
| -3% | -$20K |
|
72
NVIDIA
NVDA
$4.24T
| $642K | 0.27% |
5,927
+42
| +0.7% | +$4.55K |
|
73
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$21.6B
| $621K | 0.26% |
11,860
-307
| -3% | -$16.1K |
|
74
Everest Group
EG
$14.3B
| $604K | 0.25% |
1,663
+183
| +12% | +$66.5K |
|
75
Apple
AAPL
$3.45T
| $579K | 0.24% |
2,607
| – | – |
|